Precipio to Present BCR::ABL1 Assay Study at 2025 ASH Meeting
ByAinvest
Friday, Dec 5, 2025 10:02 am ET1min read
PRPO--
Precipio will showcase its BCR::ABL1 panel at the 2025 American Society of Hematology (ASH) Meeting. A joint study with Memorial Sloan Kettering found superior performance and concordance with two other leading platforms. The study demonstrates positive impacts on patient care and laboratory workflows. Poster presentation and results discussion are scheduled for December 8th.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet